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INTRODUCTION
Lipoprotein lipase, acting in capillary endothelium, regulates the uptake of triacylglycerol from chylomicrons and very low density lipoproteins by mammary, adipose, and other extrahepatic tissues (1) (2) (3) . Lipoprotein lipase activity of mammary gland increases in pregnant animals 2-3 days before parturition and remains high throughout lactation (4) . Lipoprotein lipase activity of adipose tissue decreases before parturition, and remains low throughout lactation (4, 5) . These changes in lipolytic activity in late pregnant rats are accompanied by a marked decrease in blood triacylglycerol concentration, and serve during lactation to divert blood triacylglycerol fatty acids from storage in adipose tissue to milk prodtuction in mammary gland (5) .1 Stutdies in hypophysectomized lactating rats showed that the changes which occur in lipoprotein lipase activity in late pregnancy are maintained during lactation by the action of prolactin, secreted from the anterior pituitary gland (6) .
There is little information concerning factors that reguilate lipoprotein lipase activity in mammary and adipose tisstue dturinig late pregnancy. Dturing this period, there are alterations in blood concentrations of several hormones-prolactin, insulin, estrogen, and progesterone-which can affect lipolytic activity in these tisstues (7) (8) (9) . Release of endogenous F prostaglandins from the utertus is markedly increased at about the time (2-3 days prepartum) that the initial changes in lipoprotein lipase activity of mammary and adipose tissue occur (10) . Administration of prostaglandin F2a (PGF2,)2 during late pregnancy initiates parturition and advances the onset of lactation in both rodents and humans (11) (12) (13) . Previously, Strauiss and Stambaugh (14) suggested that PGF2, may alter the activity of lipoprotein lipase in the rat corpus luteum near term.
The present studies were uindertaken to evaluate the effects of several prostaglanclins and prolactin on lipoprotein lipase activity in mammary rnd adipose tisstue and on serum triacylglycerol concentration in rats dturing late pregnancy. The effects of PGF2,t on sertum concentrations of prolactin, instulin, estrogen, and progesterone were also determined.
METHODS
Animals. Primiparous Sprague-Dawley rats were obtained from Charles River Breeding Laboratories (Wilmington, Mass.), and allowed free access to water and Purina National Institutes of Health Open Formula Rat and Mouse Ration #5018 (Ralston Purina Co., St. Louis, Mo.). Day 1 of pregnancy was designated as the day on which, after overnight mating, spermatozoa were found in the vaginal smear. Animals were injected during two different stages of pregnancy. Analyses on day 16 of pregnancy were made in animals injected at 08:30 and 17:00 h on days 14 and 15, and again at 08:30 on day 16. Analyses on day 20 of pregnancy were made in animals injected at 08:30 and 17:00 h on days 18 and 19, and again at 08:30 on the morning of day 20. Animals were decapitated 3-4 h after the last injection, and trunk blood was collected for analyses of senim components. Rats carrying less than six fetuses at auitopsy, and those delivering prematuirely, were excluided from the study. Lipoprotein lipase determination. Segments of inguinalabdominal mammary gland, 67 mg/ml, And parametrial adipose tissue, 100 mg/ml, were homogenized in 25 mM NH3-NH4Cl buffer, pH 8.1, containing 4 U of heparin/ml (Eli Lily) at 4°C with a Tekmar Tissumizer (Tekmar Co., Cincinnati, Ohio). Homogenates were centrifuged at 2,000g for 20 min at 4°C, and the clear supernatant fraction was removed and stored at 4°C for assay within 60 min. Preliminary experiments established that lipoprotein lipase activity in the extracts (supernatant fraction from above) was stable for at least 2 h. The extracts contained at most 0.15 ,mol of esterified fatty acids/100 ,ul (15) .
Lipoprotein lipase activity in tissue extracts was measured by the amount of fatty acids formed from serum-activated triacylglycerol. Each extract was assayed in duplicate. Each assay contained in a final volume of 500 ,ul: 50-100 ,ul of tissue extract, 4 ,umol of activated triacylglycerol, 0.63 ,umol of crystallized bovine senim albumin, 0.5 U of heparin, 5 ,umol NH4Cl, and 62 ,umol Tris-HCl, pH 8.1. The assay mixture was incubated at 37°C for 30-60 min in a shaking water bath. After incubation, lipids were extracted into hexane by a modification of the procedure of Dole (16), using hexane instead of heptane. Fatty acids in the hexane extract were partitioned into 0.05 M NaOH-50% ethanol solution (17) . Radioactivity in the hexane and NaOH-ethanol extracts was quantified with Aquasol scintillant (New England Nuclear, Boston, Mass.), in a Nuclear Chicago Mark II Scintillation Spectrometer (Nuclear-Chicago Corp., Des Plains, Ill.).
Lipolytic activities, based on tissue wet weights, were calculated from the amount of radioactive oleic acid formed during incubation. The rate of production was linear with respect to time (up to 60 min), and the amount of tissue extract added (up to 3 mg of mammary gland protein and 0.3 mg of adipose tissue protein added per assay [18] (Table   IV) .
Effect of exogenous progesterone and 2-Br-a-ergocryptine on the response to PGFaX. To examine the relation between the effects of PGFa, on serum progesterone and prolactin concentrations, and its effect on lipoprotein lipase activity in tissues, 20-day pregnant rats were injected with PGF2a, in combination with either progesterone or 2-Br-a-ergocryptine, a synthetic alkaloid inhibitor of pituitary prolactin (Tables I and II) . These findings suggested that the increase in serum prolactin might be part of the mechanism whereby PGF2, altered (9, 30, 31) . In rats, insulin levels which are elevated in mid-pregnancy decline juist before term (32) . Other studies on nonpregnant rats have shown that administration of estrogen decreases the activity of lipoprotein lipase in adipose tissue (7, 8) and increases its activity in mammary gland (8) . Estrogen levels in pregnant rats increase markedly just before parturition (10) . The present work (Table II) shows that PGF, had no effect on serum insulin or (Table I) . Alternatively, it may indicate that alterations in other components of the hormonal milieu, such as placental lactogen, which is low on day 16 and high on day 20 of pregnancy (33) , are also involved.
The effects of PGF2< on serum concentrations of progesterone observed here agree well with results of earlier studies (see references 11 and 34 for recent reviews). PGF2o reduces progesterone production by the corpus luteum of pregnancy in a number of species. This effect has been ascribed to both direct effects of PGF2, on the ovarian vasculature (35) and more recently to increased activity of a luteal 20-a-steroid dehydrogenase which metabolizes progesterone to the inactive progestin, 20-a-OH-pregn-4-ene-3-one (36) .
The partial inhibitory effects of PGE, and PGE2 on serum progesterone levels (Table III) have also been observed previously (35) . The failure of PGE, and PGE2 to alter significantly lipoprotein lipase activity in mammary and adipose tissues (Table III) may be a reflection of their inability to deplete serum progesterone levels to the same extent as PGF2. DHK-PGF2a, a major circulating metabolite of PGF2, produced effects similar to those of PGF2,X on tissue lipoprotein lipase activities and serum concentrations of triacylglycerol and hormones (Table III) . This finding was unexpected because prostaglandin metabolites such as the 13,14-dihydro-15 keto derivatives have usually been regarded as relatively inactive (37, 38) . Our results (Table III) suggest that prostaglandin metabolites, such as DHK-PGF2, may have a greater physiological relevance than generally assumed.
Serum progesterone levels in rats increase during pregnancy and remain high until several days before parturition (27) . Stimulation of milk protein and carbohydrate synthesis by lactogenic and supportive hormones (insulin, estrogens, and corticosteroids) have been shown to require the prior withdrawal of progesterone (39) (40) (41) . The results of the present work show that the reduction in serum progesterone levels induced by PGF2u, in late (i.e. 20-day) pregnant rats is associated with alterations in lipoprotein lipase activities which facilitate uptake of blood triacylglycerol by mammary gland for incorporation into milk lipids. PGF, administration thus not only advances the day of pregnancy on which parturition occurs but also results in hormonal and enzymatic changes which stimulate milk production. These considerations suggest that the release of F prostaglandins from the uterus just before parturition (10, 11, 37) 
